Therapeutic options in systemic AL amyloidosis.
Systemic amyloid light chain (AL) amyloidosis is a severe disease with unfavourable prognosis. Since the late 1970s different therapeutic modalities in AL amyloidosis have been investigated, trying to prolong survival. This review deals with the therapeutic modalities in AL amyloidosis to date, and highlights future perspectives.
van Gameren
I I
II
Department of Rheumatology, University Hospital Groningen, The Netherlands. iivangameren@xs4all.nl
Lokhorst
H
H
Hazenberg
B P C
BP
Vellenga
E
E
D000686:Amyloidosis / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D007147:Immunoglobulin Light Chains / Q000502:physiology; D000685:Serum Amyloid A Protein / Q000502:physiology
D007147:Immunoglobulin Light Chains; D000685:Serum Amyloid A Protein